Lionel D’Hondt
CHU Dinant Godinne UCL Namur(BE)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma(2009)240 cited
- → Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study(2024)137 cited
- → Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers(2012)124 cited
- → Oral mucositis induced by anticancer treatments: physiopathology and treatments(2006)87 cited
- → Prospective Randomized Study Comparing Docetaxel, Estramustine, and Prednisone With Docetaxel and Prednisone in Metastatic Hormone-Refractory Prostate Cancer(2008)87 cited
- → Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer(2017)83 cited